FDA could soon authorize COVID-19 treatment with antibody plasma - WSJ

FILE PHOTO: A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo

(Reuters) - The Food and Drug Administration (FDA) could authorize emergency use of antibody-rich blood plasma from recovered COVID-19 patients to treat people infected with the coronavirus as early as next week, the Wall Street Journal reported https://on.wsj.com/30Yfwlv on Wednesday, citing people familiar with the matter.

An FDA emergency-use authorization could allow faster access to a therapy for the pandemic that has taken the lives of more than 660,000 people globally.